CENTOGENE Receives Delisting Notice From Nasdaq
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Centogene N.V., the essential life…
0,350$
0,92%
Echtzeit-Aktienkurs Centogene N.V.
Bid:
Ask:
Nachrichten zur Centogene N.V. Aktie
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path…
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the…
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“we”…
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 14, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG),…
CENTOGENE Receives Nasdaq Non-Compliance Notice
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) (“Centogene”,…
Centogene faces Nasdaq delisting over market value shortfall By Investing.com
Centogene faces Nasdaq delisting over market value shortfall…